García-Sáenz JÁ - Search Results

1

Adoptive Cell Therapy in Breast Cancer: A Current Perspective of Next-Generation Medicine.

Fuentes-Antrás J, Guevara-Hoyer K, Baliu-Piqué M, García-Sáenz JÁ, Pérez-Segura P, Pandiella A, Ocaña A. Fuentes-Antrás J, et al. Front Oncol. 2020 Oct 27;10:605633. doi: 10.3389/fonc.2020.605633. eCollection 2020. Front Oncol. 2020. PMID: 33194771 Free PMC article. Review.

2

Immediate vs. delayed imipenem treatment in cancer patients with profound neutropenia induced by high-dose chemotherapy: results of a randomized study.

García-Sáenz JA, Martín M, Casado A, Pérez-Segura P, Manrique I, Flores L, Macias JA, Cámara JC, Perezagua C, Díaz-Rubio E. García-Sáenz JA, et al. Rev Esp Quimioter. 2002 Sep;15(3):257-63. Rev Esp Quimioter. 2002. PMID: 12582429 Clinical Trial.

3

Phase II study of pegylated liposomal doxorubicin plus vinorelbine in breast cancer with previous anthracycline exposure.

Martin M, García-Donas J, Casado A, de la Gándara I, Pérez-Segura P, García-Saenz JA, Ibáñez G, Loboff B, García-Ledo G, Moreno F, Grande E, Diaz-Rubio E. Martin M, et al. Clin Breast Cancer. 2004 Dec;5(5):353-7. doi: 10.3816/cbc.2004.n.041. Clin Breast Cancer. 2004. PMID: 15585072 Clinical Trial.

4

A HRM-based screening method detects RAD51C germ-line deleterious mutations in Spanish breast and ovarian cancer families.

Romero A, Pérez-Segura P, Tosar A, García-Saenz JA, Díaz-Rubio E, Caldés T, de la Hoya M. Romero A, et al. Breast Cancer Res Treat. 2011 Oct;129(3):939-46. doi: 10.1007/s10549-011-1543-x. Epub 2011 May 3. Breast Cancer Res Treat. 2011. PMID: 21537932

5

A Transcriptomic Immunologic Signature Predicts Favorable Outcome in Neoadjuvant Chemotherapy Treated Triple Negative Breast Tumors.

Pérez-Pena J, Tibor Fekete J, Páez R, Baliu-Piqué M, García-Saenz JÁ, García-Barberán V, Manzano A, Pérez-Segura P, Esparis-Ogando A, Pandiella A, Gyorffy B, Ocana A. Pérez-Pena J, et al. Front Immunol. 2019 Dec 18;10:2802. doi: 10.3389/fimmu.2019.02802. eCollection 2019. Front Immunol. 2019. PMID: 31921107 Free PMC article.

6

Long-Lasting Response after Pembrolizumab in a Patient with Metastatic Triple-Negative Breast Cancer.

Peinado P, Ramírez C, García-Sáenz JA, Pascual A, Fuentes-Antrás J, Vidal N, Antoñanzas M, Moreno F. Peinado P, et al. Breast Care (Basel). 2020 Aug;15(4):428-432. doi: 10.1159/000503849. Epub 2019 Oct 29. Breast Care (Basel). 2020. PMID: 32982655 Free PMC article.

7

Safety and efficacy of cyclin-dependent kinase inhibitor rechallenge following ribociclib-induced limiting hypertransaminasemia.

Fuentes-Antrás J, de Luna A, López de Sá A, Ocaña A, García-Sáenz JÁ, Moreno F. Fuentes-Antrás J, et al. Breast. 2020 Dec;54:160-163. doi: 10.1016/j.breast.2020.10.007. Epub 2020 Oct 17. Breast. 2020. PMID: 33096323 Free PMC article.

8

Genomic Mapping of Splicing-Related Genes Identify Amplifications in LSM1, CLNS1A, and ILF2 in Luminal Breast Cancer.

Noblejas-López MDM, López-Cade I, Fuentes-Antrás J, Fernández-Hinojal G, Esteban-Sánchez A, Manzano A, García-Sáenz JÁ, Pérez-Segura P, La Hoya M, Pandiella A, Győrffy B, García-Barberán V, Ocaña A. Noblejas-López MDM, et al. Cancers (Basel). 2021 Aug 16;13(16):4118. doi: 10.3390/cancers13164118. Cancers (Basel). 2021. PMID: 34439272 Free PMC article.

9

Editorial: Exercise, physical therapy, and wellbeing in breast cancer patients.

de la Torre-Montero JC, Casla-Barrio S, Herrero-López B, García-Saénz JÁ. de la Torre-Montero JC, et al. Front Oncol. 2023 Feb 14;13:1118718. doi: 10.3389/fonc.2023.1118718. eCollection 2023. Front Oncol. 2023. PMID: 36865789 Free PMC article. No abstract available.

10

Real-World Use of Highly Sensitive Liquid Biopsy Monitoring in Metastatic Breast Cancer Patients Treated with Endocrine Agents after Exposure to Aromatase Inhibitors.

Fuentes-Antrás J, Martínez-Rodríguez A, Guevara-Hoyer K, López-Cade I, Lorca V, Pascual A, de Luna A, Ramírez-Ruda C, Swindell J, Flores P, Lluch A, Cescon DW, Pérez-Segura P, Ocaña A, Jones F, Moreno F, García-Barberán V, García-Sáenz JÁ. Fuentes-Antrás J, et al. Int J Mol Sci. 2023 Jul 13;24(14):11419. doi: 10.3390/ijms241411419. Int J Mol Sci. 2023. PMID: 37511178 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

186 results

Search Page